← FDA Drug Approvals (Drugs@FDA)
DEFERASIROX
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2022-09-22
Drug application
- FDA Application #
ANDA216229- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DEFERASIROX
- Generic name
- DEFERASIROX
- Active ingredients
- DEFERASIROX
- Dosage form
- GRANULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ANNORA PHARMA
- Manufacturer
- Camber Pharmaceuticals, Inc.
- First approval
- 2022-09-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown